---
layout: splash
title: 녹십자 (006280)
excerpt: 녹십자의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 녹십자, 006280
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 117,500 | <span style="color: tomato">1.5<small>%</small></span> | P:의약품 | 20.5 | 1.0 | 1.5<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 알부민외 제조, 판매 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1989년 8월 1일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 허은철 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.gccorp.com](http://www.gccorp.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;16 | | [[발행조건확정]증권신고서(채무증권)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240216001320){:target="_blank"} |
| 02&#x2011;14 | | [현금ㆍ현물배당결정              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240214801654){:target="_blank"} |
|  | | [주주총회소집결의              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240214801642){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![006280](/stock/images/006280.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 117,500 | <span style="color: tomato">1.5<small>%</small></span> | <span style="color: tomato">2.1<small>%</small></span> | <span style="color: tomato">7.7<small>%</small></span> | <span style="color: tomato">4.4<small>%</small></span> | <span style="color: cornflowerblue">-0.6<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-6.0<small>%</small></span> | 30.4<small>%</small> | -0.20 | -31.3<small>%</small> | -14.3<small>%</small> | 0.2 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 20.5 | 1.0 | 1.5<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/006280/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=006280){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A006280&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=006280){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/006280){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/006280/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![006280](/stock/images/006280_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -6.0<small>%</small> | 30.4<small>%</small> | -0.20 | -31.3<small>%</small> | -14.3<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 1.5<small>%</small> | 30.0<small>%</small> | 0.05 | -28.3<small>%</small> | -12.3<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 0.1<small>%</small> | 23.5<small>%</small> | 0.00 | -29.7<small>%</small> | -13.1<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 11.5<small>%</small> | 20.7<small>%</small> | 0.56 | -13.5<small>%</small> | -5.1<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 5.6<small>%</small> | 20.9<small>%</small> | 0.27 | -23.3<small>%</small> | -12.5<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -23.1<small>%</small> | 16.3<small>%</small> | -1.42 | -28.0<small>%</small> | -14.4<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -13.0<small>%</small> | 14.1<small>%</small> | -0.92 | -21.9<small>%</small> | -12.8<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -4.1<small>%</small> | 7.2<small>%</small> | -0.57 | -8.3<small>%</small> | -1.1<small>%</small> |
| MACD[^fn_tech_metric_macd] | 8.9<small>%</small> | 22.5<small>%</small> | 0.40 | -21.3<small>%</small> | -10.2<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![006280](/stock/images/006280_corr.png){: .align-center}

|       | [제넥신](/095700/) | [CJ제일제당](/097950/) | [신라젠](/215600/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [녹십자홀딩스](/005250/) | [SK케미칼](/285130/) | [강원랜드](/035250/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![006280](/stock/images/006280_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}